melatonin has been researched along with Communicable Diseases in 4 studies
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin (MLT) is an amine hormone secreted mainly by the pineal gland." | 6.61 | [Advances in the role of melatonin in infectious diseases: A review]. ( Jin, B; Ma, Y; Tang, K; Zhang, C; Zhang, Y, 2019) |
| "Melatonin is a hormone secreted by the pineal gland in response to photoperiods and influences many important biological processes." | 6.40 | Melatonin, immune modulation and aging. ( Ardestani, SK; Elliott, KK; Inserra, PF; Liang, B; Molitor, M; Watson, RR; Zhang, Z, 1997) |
| "Acute inflammation of the vasculature, genetic susceptibility and immunopathogenesis based on a transmittable and infectious origin, are the pathologic events involved in the early inflammatory etiology and progression of this disease." | 5.48 | Melatonin: A hypothesis for Kawasaki disease treatment. ( Gil-Martín, E; López-Muñoz, F; Patiño, P; Ramos, E; Reiter, RJ; Romero, A, 2018) |
| "Melatonin (MLT) is an amine hormone secreted mainly by the pineal gland." | 2.61 | [Advances in the role of melatonin in infectious diseases: A review]. ( Jin, B; Ma, Y; Tang, K; Zhang, C; Zhang, Y, 2019) |
| "Melatonin has been also used as a complementary treatment in anaesthesia, hemodialysis, in vitro fertilization and neonatal care." | 2.46 | Clinical uses of melatonin: evaluation of human trials. ( Mediavilla, MD; Reiter, RJ; Sánchez-Barceló, EJ; Tan, DX, 2010) |
| "Melatonin is a hormone secreted by the pineal gland in response to photoperiods and influences many important biological processes." | 2.40 | Melatonin, immune modulation and aging. ( Ardestani, SK; Elliott, KK; Inserra, PF; Liang, B; Molitor, M; Watson, RR; Zhang, Z, 1997) |
| "Acute inflammation of the vasculature, genetic susceptibility and immunopathogenesis based on a transmittable and infectious origin, are the pathologic events involved in the early inflammatory etiology and progression of this disease." | 1.48 | Melatonin: A hypothesis for Kawasaki disease treatment. ( Gil-Martín, E; López-Muñoz, F; Patiño, P; Ramos, E; Reiter, RJ; Romero, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramos, E | 1 |
| Patiño, P | 1 |
| Reiter, RJ | 2 |
| Gil-Martín, E | 1 |
| López-Muñoz, F | 1 |
| Romero, A | 1 |
| Ma, Y | 2 |
| Tang, K | 1 |
| Zhang, C | 1 |
| Zhang, Y | 2 |
| Jin, B | 1 |
| Sánchez-Barceló, EJ | 1 |
| Mediavilla, MD | 1 |
| Tan, DX | 1 |
| Zhang, Z | 1 |
| Inserra, PF | 1 |
| Liang, B | 1 |
| Ardestani, SK | 1 |
| Elliott, KK | 1 |
| Molitor, M | 1 |
| Watson, RR | 1 |
3 reviews available for melatonin and Communicable Diseases
| Article | Year |
|---|---|
[Advances in the role of melatonin in infectious diseases: A review].
Topics: Communicable Diseases; Cytokines; Humans; Immune System; Inflammation; Melatonin | 2019 |
Clinical uses of melatonin: evaluation of human trials.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Communicable Diseases; Endocrine System Diseases; | 2010 |
Melatonin, immune modulation and aging.
Topics: Aging; Animals; Antibody Formation; Communicable Diseases; Hormones; Humans; Immunity, Innate; Lymph | 1997 |
1 other study available for melatonin and Communicable Diseases
| Article | Year |
|---|---|
Melatonin: A hypothesis for Kawasaki disease treatment.
Topics: Anti-Inflammatory Agents; Aspirin; Child; Child, Preschool; Communicable Diseases; Genetic Predispos | 2018 |